Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents

BACKGROUND: In gastroesophageal reflux disease (GERD), the frequency of heartburn symptoms and erosive esophagitis (EE) increases with age in children and adolescents. Proton pump inhibitor, dexlansoprazole, is approved for healing EE of all grades, maintenance of healed EE, relief of heartburn, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gremse, David, Gold, Benjamin D., Pilmer, Betsy, Hunt, Barbara, Korczowski, Bartosz, Perez, Maria Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514063/
https://www.ncbi.nlm.nih.gov/pubmed/30390234
http://dx.doi.org/10.1007/s10620-018-5325-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514063/
https://www.ncbi.nlm.nih.gov/pubmed/30390234
http://dx.doi.org/10.1007/s10620-018-5325-8

Ejemplares similares